GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Beta

Fresenius SE KGaA (XTER:FRE) Beta : 1.15 (As of Dec. 15, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-15), Fresenius SE KGaA's Beta is 1.15.


Fresenius SE KGaA Beta Historical Data

The historical data trend for Fresenius SE KGaA's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Beta Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 1.06 1.10 1.09 1.08

Fresenius SE KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 1.08 1.04 1.03 1.18

Competitive Comparison of Fresenius SE KGaA's Beta

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Beta distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Beta falls into.



Fresenius SE KGaA Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Fresenius SE KGaA  (XTER:FRE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Fresenius SE KGaA Beta Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
Executives
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Robert Möller Board of Directors
Pierluigi Antonelli Board of Directors
Dr. Frank Appel Supervisory Board
Dr. Michael Moser Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA Headlines

No Headlines